These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

477 related articles for article (PubMed ID: 16569679)

  • 1. IL-1beta, but not IL-1alpha, is required for antigen-specific T cell activation and the induction of local inflammation in the delayed-type hypersensitivity responses.
    Nambu A; Nakae S; Iwakura Y
    Int Immunol; 2006 May; 18(5):701-12. PubMed ID: 16569679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T cell responses induced by the parenteral injection of antigen-modified syngeneic cells. I. Induction, characterization, and regulation of antigen-specific T helper cells involved in delayed-type hypersensitivity responses.
    Miller SD; Butler LD
    J Immunol; 1983 Jul; 131(1):77-85. PubMed ID: 6190929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antigen-specific suppression of established arthritis in mice by dendritic cells deficient in NF-kappaB.
    Martin E; Capini C; Duggan E; Lutzky VP; Stumbles P; Pettit AR; O'Sullivan B; Thomas R
    Arthritis Rheum; 2007 Jul; 56(7):2255-66. PubMed ID: 17599748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunization with wild-type p53 gene sequences coadministered with Flt3 ligand induces an antigen-specific type 1 T-cell response.
    Parajuli P; Pisarev V; Sublet J; Steffel A; Varney M; Singh R; LaFace D; Talmadge JE
    Cancer Res; 2001 Nov; 61(22):8227-34. PubMed ID: 11719454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delayed-type hypersensitivity initiation by early-acting cells that are antigen mismatched or MHC incompatible with late-acting, delayed-type hypersensitivity effector T cells.
    Ptak W; Herzog WR; Askenase PW
    J Immunol; 1991 Jan; 146(2):469-75. PubMed ID: 1987274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Attenuation of delayed-type hypersensitivity by fullerene treatment.
    Yamashita K; Sakai M; Takemoto N; Tsukimoto M; Uchida K; Yajima H; Oshio S; Takeda K; Kojima S
    Toxicology; 2009 Jun; 261(1-2):19-24. PubMed ID: 19376187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The DTH-initiating Thy-1+ cell is double-negative (CD4-, CD8-) and CD3-, and expresses IL-3 receptors, but no IL-2 receptors.
    Herzog WR; Ferreri NR; Ptak W; Askenase PW
    J Immunol; 1989 Nov; 143(10):3125-33. PubMed ID: 2478617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Defective elicitation of delayed-type hypersensitivity in W/Wv and SI/SId mast cell-deficient mice.
    Askenase PW; Van Loveren H; Kraeuter-Kops S; Ron Y; Meade R; Theoharides TC; Nordlund JJ; Scovern H; Gerhson MD; Ptak W
    J Immunol; 1983 Dec; 131(6):2687-94. PubMed ID: 6605986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Viral IL-10 gene transfer inhibits DTH responses to soluble antigens: evidence for involvement of genetically modified dendritic cells and macrophages.
    Whalen JD; Thomson AW; Lu L; Robbins PD; Evans CH
    Mol Ther; 2001 Dec; 4(6):543-50. PubMed ID: 11735338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of cytokines in mediating mechanical hypernociception in a model of delayed-type hypersensitivity in mice.
    Cunha TM; Verri WA; Valério DA; Guerrero AT; Nogueira LG; Vieira SM; Souza DG; Teixeira MM; Poole S; Ferreira SH; Cunha FQ
    Eur J Pain; 2008 Nov; 12(8):1059-68. PubMed ID: 18372199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-4 is essential for the systemic transfer of delayed hypersensitivity by T cell lines. Role of gamma/delta cells.
    Dieli F; Asherson GL; Romano GC; Sireci G; Gervasi F; Salerno A
    J Immunol; 1994 Mar; 152(6):2698-704. PubMed ID: 8144876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Murine lymph node antigen presenting cells are the main source of interleukin-6 in the initiation of delayed-type hypersensitivity.
    Ulrich P; Vohr HW
    Eur Cytokine Netw; 1996 Sep; 7(3):401-7. PubMed ID: 8954184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dendritic cell-derived IL-15 controls the induction of CD8 T cell immune responses.
    Rückert R; Brandt K; Bulanova E; Mirghomizadeh F; Paus R; Bulfone-Paus S
    Eur J Immunol; 2003 Dec; 33(12):3493-503. PubMed ID: 14635060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A crucial role for interleukin (IL)-1 in the induction of IL-17-producing T cells that mediate autoimmune encephalomyelitis.
    Sutton C; Brereton C; Keogh B; Mills KH; Lavelle EC
    J Exp Med; 2006 Jul; 203(7):1685-91. PubMed ID: 16818675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute CD4+ T lymphocyte-dependent interleukin-1-driven arthritis selectively requires interleukin-2 and interleukin-4, joint macrophages, granulocyte-macrophage colony-stimulating factor, interleukin-6, and leukemia inhibitory factor.
    Lawlor KE; Wong PK; Campbell IK; van Rooijen N; Wicks IP
    Arthritis Rheum; 2005 Dec; 52(12):3749-54. PubMed ID: 16320325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional hierarchy and relative contribution of the CD28/B7 and ICOS/B7-H2 costimulatory pathways to T cell-mediated delayed-type hypersensitivity.
    Wong SC; Tan AH; Lam KP
    Cell Immunol; 2009; 256(1-2):64-71. PubMed ID: 19249753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Splenic dendritic cells pulsed with Ixodes ricinus tick saliva prime naive CD4+T to induce Th2 cell differentiation in vitro and in vivo.
    Mejri N; Brossard M
    Int Immunol; 2007 Apr; 19(4):535-43. PubMed ID: 17344202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of proinflammatory cytokines on Actinobacillus actinomycetemcomitans specific IgG responses.
    Tanaka S; Fakher M; Barbour SE; Schenkein HA; Tew JG
    J Periodontal Res; 2006 Feb; 41(1):1-9. PubMed ID: 16409249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble CD4 suppresses delayed-type hypersensitivity reaction of CD4 loosing mice by inhibiting INFgamma production.
    Wang CR
    J Microbiol Immunol Infect; 2000 Jun; 33(2):93-9. PubMed ID: 10917878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-17 production from activated T cells is required for the spontaneous development of destructive arthritis in mice deficient in IL-1 receptor antagonist.
    Nakae S; Saijo S; Horai R; Sudo K; Mori S; Iwakura Y
    Proc Natl Acad Sci U S A; 2003 May; 100(10):5986-90. PubMed ID: 12721360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.